ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

a study on Cirrhosis High Blood Pressure

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
estimated completion
Principal Investigator
by Jennifer Lai, MD
Headshot of Jennifer Lai
Jennifer Lai

Description

Summary

ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions.

Official Title

Advancing Liver Therapeutic Approaches (ALTA). The ALTA Consortium Study Group for the Management of Portal Hypertension - A 5-year Longitudinal Observational Study of Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement

Keywords

Cirrhosis, Liver Transjugular Intrahepatic Portosystemic Shunt (TIPS) Liver Cirrhosis

Eligibility

You can join if…

Open to people ages 18 years and up

  • Subjects over the age of 18 able to provide consent or have a legally authorized consent in the event the subject is unable to consent due to a transient clinical condition
  • Subject scheduled to undergo a TIPS procedure

You CAN'T join if...

  • Minors under the age of 18 at the time of enrollment
  • Prisoners
  • Pregnant Women
  • Subjects undergoing TIPS placement as part of an investigational study outside of usual clinical care

Locations

  • University of California San Francisco accepting new patients
    San Francisco California 94115 United States
  • Stanford accepting new patients
    Redwood City California 94063 United States

Lead Scientist at UCSF

  • Jennifer Lai, MD
    Dr. Lai is a practicing general and transplant hepatologist who specializes in caring for patients across the entire spectrum of liver disease, from diagnosis to liver transplant—and beyond. Dr. Lai is also a clinical investigator with a robust research program dedicated to improving the lives of patients with chronic liver disease.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Northwestern University
ID
NCT03973372
Study Type
Observational [Patient Registry]
Participants
Expecting 1000 study participants
Last Updated
Contact us about this trial